Bilateral neurorethinovasculitis associated with COVID-19 infection in a girl 17 years old
- Authors: Denisova E.1, Demchenko E.N1, Geraskina E.A.1, Khrabrova M.A.1, Panova A.Y.1
-
Affiliations:
- Helmholtz National Medical Research Center of Eye Diseases
- Issue: Vol 16, No 2 (2021)
- Pages: 41-52
- Section: Case reports
- URL: https://ruspoj.com/1993-1859/article/view/70447
- DOI: https://doi.org/10.17816/rpoj70447
- ID: 70447
Cite item
Abstract
Despite dominant lung lesions, new coronavirus infection (COVID-19) can influence almost any organ, including eyes. According to modern data, frequency of eye damage by COVID-19 reaches 32%, and spectrum of clinical manifestations is diverse. Changes are observed both in the anterior (mainly conjunctivitis) and posterior (mostly retinal vascular thrombosis, optic neuritis, neuroretinitis) segments of the eye, and the timing of their occurrence varies from the first (sometimes the only) clinical symptoms of the disease to the development at the peak or during the period of convalescence from COVID-19.
In children symptomatic COVID-19 infection is diagnosed less frequently than in adults, and ophthalmic manifestations are less investigated. This article describes a case of bilateral neuroretinovasculitis in a 17-year-old girl with a mild course of COVID-19, that arose 3 weeks after the onset of the disease, which broadens the understanding of ocular manifestations of COVID-19 in children.
We emphasize that an ophthalmologist should know ocular manifestations of COVID-19, which can help in the diagnosis and further study of the frequency and spectrum of ophthalmic symptoms, especially in children
Full Text

About the authors
Ekaterina Denisova
Helmholtz National Medical Research Center of Eye Diseases
Email: deale_2006@inbox.ru
ORCID iD: 0000-0003-3735-6249
PhD, researcher, department of children’s eye pathology
Russian Federation, MoscowE. N Demchenko
Helmholtz National Medical Research Center of Eye Diseases
Email: dem-andrej@yandex.ru
ORCID iD: 0000-0001-6523-5191
PhD
Russian Federation, MoscowElizaveta A. Geraskina
Helmholtz National Medical Research Center of Eye Diseases
Email: slinko.amalgam@yandex.ru
ORCID iD: 0000-0002-5306-2534
graduate student
Russian Federation, MoscowMariia A. Khrabrova
Helmholtz National Medical Research Center of Eye Diseases
Email: lovin68@yandex.ru
ORCID iD: 0000-0001-9422-4264
graduate student
Russian Federation, MoscowAnna Y. Panova
Helmholtz National Medical Research Center of Eye Diseases
Author for correspondence.
Email: annie_panova18@mail.ru
ORCID iD: 0000-0003-2103-1570
junior reseacher
Russian Federation, MoscowReferences
- Abrishami M, Tohidinezhad F, Daneshvar R, et al. Ocular Manifestations of Hospitalized Patients with COVID-19 in Northeast of Iran. Ocul Immunol Inflamm. 2020;28(5):739-744. doi: 10.1080/09273948.2020.1773868
- Atum M, Boz AAE, Cakir B, et al. Evaluation of Conjunctival Swab PCR Results in Patients with SARS-CoV-2 Infection. Ocul Immunol Inflamm. 2020;28(5):745-748. doi: 10.1080/09273948.2020.1775261
- Casalino G, Monaco G, Di Sarro PP, et al. Coronavirus disease 2019 presenting with conjunctivitis as the first symptom. Eye (Lond). 2020;34(7):1235-1236. doi: 10.1038/s41433-020-0909-x
- Chen L, Liu M, Zhang Z, et al. Ocular manifestations of a hospitalised patient with confirmed 2019 novel coronavirus disease. Br J Ophthalmol. 2020;104(6):748-751. doi: 10.1136/bjophthalmol-2020-316304
- Chen L, Deng C, Chen X, et al. Ocular manifestations and clinical characteristics of 535 cases of COVID-19 in Wuhan, China: a cross-sectional study. Acta Ophthalmol. 2020;98(8):e951-e959. doi: 10.1111/aos.14472
- Daruich A, Martin D, Bremond-Gignac D. Ocular manifestation as first sign of Coronavirus Disease 2019 (COVID-19): Interest of telemedicine during the pandemic context. J Fr Ophtalmol. 2020;43(5):389-391. doi: 10.1016/j.jfo.2020.04.002
- Guemes-Villahoz N, Burgos-Blasco B, Arribi-Vilela A, et al. Detecting SARS-CoV-2 RNA in conjunctival secretions: Is it a valuable diagnostic method of COVID-19? J Med Virol. 2021;93(1):383-388. doi: 10.1002/jmv.26219
- Khavandi S, Tabibzadeh E, Naderan M, Shoar S. Corona virus disease-19 (COVID-19) presenting as conjunctivitis: atypically high-risk during a pandemic. Cont Lens Anterior Eye. 2020;43(3):211-212. doi: 10.1016/j.clae.2020.04.010
- Mahmoud H, Ammar H, El Rashidy A, et al. Assessment of Coronavirus in the Conjunctival Tears and Secretions in Patients with SARS-CoV-2 Infection in Sohag Province, Egypt. Clin Ophthalmol. 2020;14:2701-2708. doi: 10.2147/OPTH.S270006
- Marquezan MC, Marquezam JP, Nascimento H, et al. Conjunctivitis Related to not Severe COVID-19: A Case Report. Ocul Immunol Inflamm. 2020:1-3. doi: 10.1080/09273948.2020.1837186
- Maychuk DY, Atlas SN, Loshkareva AO. Ocular manifestations of coronavirus infection COVID-19 (clinical observation). Vestn Oftalmol. 2020;136(4):118-123. (In Russ). doi: 10.17116/oftalma2020136041118
- Meduri A, Oliverio GW, Mancuso G, et al. Ocular surface manifestation of COVID-19 and tear film analysis. Sci Rep. 2020;10(1):20178. doi: 10.1038/s41598-020-77194-9
- Ozturker ZK. Conjunctivitis as sole symptom of COVID-19: A case report and review of literature. Eur J Ophthalmol. 2021;31(2):NP161-NP166. doi: 10.1177/1120672120946287
- Scalinci SZ, Trovato Battagliola E. Conjunctivitis can be the only presenting sign and symptom of COVID-19. IDCases. 2020;20:e00774. doi: 10.1016/j.idcr.2020.e00774
- Sindhuja K, Lomi N, Asif MI, Tandon R. Clinical profile and prevalence of conjunctivitis in mild COVID-19 patients in a tertiary care COVID-19 hospital: A retrospective cross-sectional study. Indian J Ophthalmol. 2020;68(8):1546-1550. doi: 10.4103/ijo.IJO_1319_20
- Sirakaya E, Sahiner M, Aslan Sirakaya H. A Patient With Bilateral Conjunctivitis Positive for SARS-CoV-2 RNA in a Conjunctival Sample. Cornea. 2021;40(3):383-386. doi: 10.1097/ICO.0000000000002485
- Wu P, Duan F, Luo C, et al. Characteristics of Ocular Findings of Patients With Coronavirus Disease 2019 (COVID-19) in Hubei Province, China. JAMA Ophthalmol. 2020;138(5):575-578. doi: 10.1001/jamaophthalmol.2020.1291
- Xia J, Tong J, Liu M, et al. Evaluation of coronavirus in tears and conjunctival secretions of patients with SARS-CoV-2 infection. J Med Virol. 2020;92(6):589-594. doi: 10.1002/jmv.25725
- Zhang X, Chen X, Chen L, et al. The evidence of SARS-CoV-2 infection on ocular surface. Ocul Surf. 2020;18(3):360-362. doi: 10.1016/j.jtos.2020.03.010
- Karimi S, Arabi A, Shahraki T, Safi S. Detection of severe acute respiratory syndrome Coronavirus-2 in the tears of patients with Coronavirus disease 2019. Eye (Lond). 2020;34(7):1220-1223. doi: 10.1038/s41433-020-0965-2
- Seah IYJ, Anderson DE, Kang AEZ, et al. Assessing Viral Shedding and Infectivity of Tears in Coronavirus Disease 2019 (COVID-19) Patients. Ophthalmology. 2020;127(7):977-979. doi: 10.1016/j.ophtha.2020.03.026
- Zhou Y, Duan C, Zeng Y, et al. Ocular Findings and Proportion with Conjunctival SARS-COV-2 in COVID-19 Patients. Ophthalmology. 2020;127(7):982-983. doi: 10.1016/j.ophtha.2020.04.028
- Cheema M, Aghazadeh H, Nazarali S, et al. Keratoconjunctivitis as the initial medical presentation of the novel coronavirus disease 2019 (COVID-19). Can J Ophthalmol. 2020;55(4):e125-e129. doi: 10.1016/j.jcjo.2020.03.003
- Guo D, Xia J, Wang Y, et al. Relapsing viral keratoconjunctivitis in COVID-19: a case report. Virol J. 2020;17(1):97. doi: 10.1186/s12985-020-01370-6
- Mendez Mangana C, Barraquer Kargacin A, Barraquer RI. Episcleritis as an ocular manifestation in a patient with COVID-19. Acta Ophthalmol. 2020;98(8):e1056-e1057. doi: 10.1111/aos.14484
- Otaif W, Al Somali AI, Al Habash A. Episcleritis as a possible presenting sign of the novel coronavirus disease: A case report. Am J Ophthalmol Case Rep. 2020;20:100917. doi: 10.1016/j.ajoc.2020.100917
- Kumar K, Prakash AA, Gangasagara SB, et al. Presence of viral RNA of SARS-CoV-2 in conjunctival swab specimens of COVID-19 patients. Indian J Ophthalmol. 2020;68(6):1015-1017. doi: 10.4103/ijo.IJO_1287_20
- Li X, Chan JF, Li KK, et al. Detection of SARS-CoV-2 in conjunctival secretions from patients without ocular symptoms. Infection. 2021;49(2):257-265. doi: 10.1007/s15010-020-01524-2
- Xie HT, Jiang SY, Xu KK, et al. SARS-CoV-2 in the ocular surface of COVID-19 patients. Eye Vis (Lond). 2020;7:23. doi: 10.1186/s40662-020-00189-0
- Kaya H, Caliskan A, Okul M, et al. Detection of SARS-CoV-2 in the tears and conjunctival secretions of Coronavirus disease 2019 patients. J Infect Dev Ctries. 2020;14(9):977-981. doi: 10.3855/jidc.13224
- Sun CB, Wang YY, Liu GH, Liu Z. Role of the Eye in Transmitting Human Coronavirus: What We Know and What We Do Not Know. Front Public Health. 2020;8:155. doi: 10.3389/fpubh.2020.00155
- Ulhaq ZS, Soraya GV. The prevalence of ophthalmic manifestations in COVID-19 and the diagnostic value of ocular tissue/fluid. Graefes Arch Clin Exp Ophthalmol. 2020;258(6):1351-1352. doi: 10.1007/s00417-020-04695-8
- Colavita F, Lapa D, Carletti F, et al. SARS-CoV-2 Isolation From Ocular Secretions of a Patient With COVID-19 in Italy With Prolonged Viral RNA Detection. Ann Intern Med. 2020;173(3):242-243. doi: 10.7326/M20-1176
- Gonzalez-Lopez JJ, Felix Espinar B, Ye-Zhu C. Symptomatic Retinal Microangiophaty in a Patient with Coronavirus Disease 2019 (COVID-19): Single Case Report. Ocul Immunol Inflamm. 2020:1-3. doi: 10.1080/09273948.2020.1852260
- Invernizzi A, Torre A, Parrulli S, et al. Retinal findings in patients with COVID-19: Results from the SERPICO-19 study. EClinicalMedicine. 2020;27:100550. doi: 10.1016/j.eclinm.2020.100550
- Landecho MF, Yuste JR, Gandara E, et al. COVID-19 retinal microangiopathy as an in vivo biomarker of systemic vascular disease? J Intern Med. 2021;289(1):116-120. doi: 10.1111/joim.13156
- Lani-Louzada R, Ramos C, Cordeiro RM, Sadun AA. Retinal changes in COVID-19 hospitalized cases. PLoS One. 2020;15(12):e0243346. doi: 10.1371/journal.pone.0243346
- Marinho PM, Marcos AAA, Romano AC, et al. Retinal findings in patients with COVID-19. Lancet. 2020;395(10237):1610. doi: 10.1016/S0140-6736(20)31014-X
- Gaba WH, Ahmed D, Al Nuaimi RK, et al. Bilateral Central Retinal Vein Occlusion in a 40-Year-Old Man with Severe Coronavirus Disease 2019 (COVID-19) Pneumonia. Am J Case Rep. 2020;21:e927691. doi: 10.12659/AJCR.927691
- Invernizzi A, Pellegrini M, Messenio D, et al. Impending Central Retinal Vein Occlusion in a Patient with Coronavirus Disease 2019 (COVID-19). Ocul Immunol Inflamm. 2020;28(8):1290-1292. doi: 10.1080/09273948.2020.1807023
- Raval N, Djougarian A, Lin J. Central retinal vein occlusion in the setting of COVID-19 infection. J Ophthalmic Inflamm Infect. 2021;11:10. doi: 10.1186/s12348-021-00241-7
- Sheth JU, Narayanan R, Goyal J, Goyal V. Retinal vein occlusion in COVID-19: A novel entity. Indian J Ophthalmol. 2020;68(10):2291-2293. doi: 10.4103/ijo.IJO_2380_20
- Yahalomi T, Pikkel J, Arnon R, Pessach Y. Central retinal vein occlusion in a young healthy COVID-19 patient: A case report. Am J Ophthalmol Case Rep. 2020;20:100992. doi: 10.1016/j.ajoc.2020.100992
- Acharya S, Diamond M, Anwar S, et al. Unique case of central retinal artery occlusion secondary to COVID-19 disease. IDCases. 2020;21:e00867. doi: 10.1016/j.idcr.2020.e00867
- Dumitrascu OM, Volod O, Bose S, et al. Acute ophthalmic artery occlusion in a COVID-19 patient on apixaban. J Stroke Cerebrovasc Dis. 2020;29(8):104982. doi: 10.1016/j.jstrokecerebrovasdis.2020.104982
- Gascon P, Briantais A, Bertrand E, et al. Covid-19-Associated Retinopathy: A Case Report. Ocul Immunol Inflamm. 2020;28(8):1293-1297. doi: 10.1080/09273948.2020.1825751
- Virgo J, Mohamed M. Paracentral acute middle maculopathy and acute macular neuroretinopathy following SARS-CoV-2 infection. Eye (Lond). 2020;34(12):2352-2353. doi: 10.1038/s41433-020-1069-8
- Insausti-Garcia A, Reche-Sainz JA, Ruiz-Arranz C, et al. Papillophlebitis in a COVID-19 patient: Inflammation and hypercoagulable state. Eur J Ophthalmol. 2020:1120672120947591. doi: 10.1177/1120672120947591
- Bettach E, Zadok D, Weill Y, et al. Bilateral anterior uveitis as a part of a multisystem inflammatory syndrome secondary to COVID-19 infection. J Med Virol. 2021;93(1):139-140. doi: 10.1002/jmv.26229
- Zago Filho LA, Lima LH, Melo GB, et al. Vitritis and Outer Retinal Abnormalities in a Patient with COVID-19. Ocul Immunol Inflamm. 2020;28(8):1298-1300. doi: 10.1080/09273948.2020.1821898
- Sawalha K, Adeodokun S, Kamoga GR. COVID-19-Induced Acute Bilateral Optic Neuritis. J Investig Med High Impact Case Rep. 2020;8:2324709620976018. doi: 10.1177/2324709620976018
- Benito-Pascual B, Gegundez JA, Diaz-Valle D, et al. Panuveitis and Optic Neuritis as a Possible Initial Presentation of the Novel Coronavirus Disease 2019 (COVID-19). Ocul Immunol Inflamm. 2020;28(6):922-925. doi: 10.1080/09273948.2020.1792512
- Zhou S, Jones-Lopez EC, Soneji DJ, et al. Myelin Oligodendrocyte Glycoprotein Antibody-Associated Optic Neuritis and Myelitis in COVID-19. J Neuroophthalmol. 2020;40(3):398-402. doi: 10.1097/WNO.0000000000001049
- Novi G, Rossi T, Pedemonte E, et al. Acute disseminated encephalomyelitis after SARS-CoV-2 infection. Neurol Neuroimmunol Neuroinflamm. 2020;7(5). doi: 10.1212/NXI.0000000000000797
- Gutierrez-Ortiz C, Mendez-Guerrero A, Rodrigo-Rey S, et al. Miller Fisher syndrome and polyneuritis cranialis in COVID-19. Neurology. 2020;95(5):e601-e605. doi: 10.1212/WNL.0000000000009619
- Martinez Diaz M, Copete Piqueras S, Blanco Marchite C, Vahdani K. Acute dacryoadenitis in a patient with SARS-CoV-2 infection. Orbit. 2021:1-4. doi: 10.1080/01676830.2020.1867193
- Ludvigsson JF. Systematic review of COVID-19 in children shows milder cases and a better prognosis than adults. Acta Paediatr. 2020;109(6):1088-1095. doi: 10.1111/apa.15270
- Chiotos K, Bassiri H, Behrens EM, et al. Multisystem Inflammatory Syndrome in Children During the Coronavirus 2019 Pandemic: A Case Series. J Pediatric Infect Dis Soc. 2020;9(3):393-398. doi: 10.1093/jpids/piaa069
- Riphagen S, Gomez X, Gonzalez-Martinez C, et al. Hyperinflammatory shock in children during COVID-19 pandemic. Lancet. 2020;395(10237):1607-1608. doi: 10.1016/S0140-6736(20)31094-1
- Ma N, Li P, Wang X, et al. Ocular Manifestations and Clinical Characteristics of Children With Laboratory-Confirmed COVID-19 in Wuhan, China. JAMA Ophthalmol. 2020;138(10):1079-1086. doi: 10.1001/jamaophthalmol.2020.3690
- Valente P, Iarossi G, Federici M, et al. Ocular manifestations and viral shedding in tears of pediatric patients with coronavirus disease 2019: a preliminary report. J AAPOS. 2020;24(4):212-215. doi: 10.1016/j.jaapos.2020.05.002
- Wu P, Liang L, Chen C, Nie S. A child confirmed COVID-19 with only symptoms of conjunctivitis and eyelid dermatitis. Graefes Arch Clin Exp Ophthalmol. 2020;258(7):1565-1566. doi: 10.1007/s00417-020-04708-6
- Quaranta L, Rovida F, Riva I, et al. Identification of SARS-CoV-2 RNA in the conjunctival swab of an Italian pediatric patient affected with COVID-19: A case report. Eur J Ophthalmol. 2020:1120672120977822. doi: 10.1177/1120672120977822
- Walinjkar JA, Makhija SC, Sharma HR, et al. Central retinal vein occlusion with COVID-19 infection as the presumptive etiology. Indian J Ophthalmol. 2020;68(11):2572-2574. doi: 10.4103/ijo.IJO_2575_20
- de Ruijter NS, Kramer G, Gons RAR, Hengstman GJD. Neuromyelitis optica spectrum disorder after presumed coronavirus (COVID-19) infection: A case report. Mult Scler Relat Disord. 2020;46:102474. doi: 10.1016/j.msard.2020.102474
- Turbin RE, Wawrzusin PJ, Sakla NM, et al. Orbital cellulitis, sinusitis and intracranial abnormalities in two adolescents with COVID-19. Orbit. 2020;39(4):305-310. doi: 10.1080/01676830.2020.1768560
- Leonardi A, Rosani U, Brun P. Ocular Surface Expression of SARS-CoV-2 Receptors. Ocul Immunol Inflamm. 2020;28(5):735-738. doi: 10.1080/09273948.2020.1772314
- Roehrich H, Yuan C, Hou JH. Immunohistochemical Study of SARS-CoV-2 Viral Entry Factors in the Cornea and Ocular Surface. Cornea. 2020;39(12):1556-1562. doi: 10.1097/ICO.0000000000002509
- Salamanna F, Maglio M, Landini MP, Fini M. Body Localization of ACE-2: On the Trail of the Keyhole of SARS-CoV-2. Front Med (Lausanne). 2020;7:594495. doi: 10.3389/fmed.2020.594495
- Senanayake P, Drazba J, Shadrach K, et al. Angiotensin II and its receptor subtypes in the human retina. Invest Ophthalmol Vis Sci. 2007;48(7):3301-3311. doi: 10.1167/iovs.06-1024
- Zhou L, Xu Z, Castiglione GM, et al. ACE2 and TMPRSS2 are expressed on the human ocular surface, suggesting susceptibility to SARS-CoV-2 infection. Ocul Surf. 2020;18(4):537-544. doi: 10.1016/j.jtos.2020.06.007
- Sawant OB, Singh S, Wright RE, 3rd, et al. Prevalence of SARS-CoV-2 in human post-mortem ocular tissues. Ocul Surf. 2021;19:322-329. doi: 10.1016/j.jtos.2020.11.002
- Neroev VV, Krichevskaya GI, Balatskaya NV. COVID-19 and problems of ophthalmology. Russian Ophthalmological Journal. 2020;13(4):99-104. doi: 10.21516/2072-0076-2020-13-4-99-104
- Neroev VV, Kiseleva TN, Eliseeva EK. Ophthalmological aspects of coronavirus infections. Russian Ophthalmological Journal. 2021;14(1):7-14. doi: 10.21516/2072-0076-2021-14-1-7-14
- Conde Cardona G, Quintana Pajaro LD, Quintero Marzola ID, et al. Neurotropism of SARS-CoV 2: Mechanisms and manifestations. J Neurol Sci. 2020;412:116824. doi: 10.1016/j.jns.2020.116824
- Varga Z, Flammer AJ, Steiger P, et al. Endothelial cell infection and endotheliitis in COVID-19. Lancet. 2020;395(10234):1417-1418. doi: 10.1016/S0140-6736(20)30937-5
- Casagrande M, Fitzek A, Puschel K, et al. Detection of SARS-CoV-2 in Human Retinal Biopsies of Deceased COVID-19 Patients. Ocul Immunol Inflamm. 2020;28(5):721-725. doi: 10.1080/09273948.2020.1770301
Supplementary files
